Arena Pharmaceuticals Inc. (ARNA)

35.94 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 35.94

Price Open 35.85

Volume: 635,541

Avg Volume: 522,287

Market Cap: 1.77B

P/E Ratio -14.73

52 Wk Range 20.02-50.05



ARNA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
46.63M
2.93M
6.70
6.29%

2018-07-13
46.51M
3.3M
5.23
7.09%

2018-06-29
46.51M
3.44M
4.96
7.39%

2018-06-15
46.51M
3.18M
4.94
6.83%




ARNA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
N/A
-0.70 (3)
-0.78
-0.08

2018-03-14
Q4 2017
BTO
-0.65 (3)
-0.78
-0.08

2018-03-13
Q4 2017
N/A
-0.64 (3)
-0.78
-0.08

2017-11-07
Q3 2017
AMC
-0.66 (4)
-0.78
-0.08

News

Is The Bottom In For Celgene? (2018-08-14 09:00 SeekingAlpha)

Celgene Corporation ( CELG ) has had a less than ideal past 10 months. Hitting highs in early October 2017 of $147.17, the stock fell to $74.13 in May 2018. A 50 percent drop, or a 50 percent pop, is standard for many of the smaller biotechs I cover, but not normally, the domain of a $60B biop…

 

Liquidia: Is It Worth Getting On Board Early? (2018-08-13 22:26 SeekingAlpha)

Liquidia Technologies ( LQDA ) is a very interesting IPO story in 2018. The pharmaceutical upstart recently completed its IPO, with the stock going public at $11 per share. Over the past couple of weeks, shares have risen some 20% to $13 and change. Playing a stock on IPO can be a dangerous ga…

 


Statistics

Shares Outstanding: 49.35M

Top 15 Institution Percent: 76.70

Price To Sales: 191.01

Price To Book: 3.20

Revenue: 7.95M

Gross Profit: 4.99M

Cash: 278.74M

Debt: 62.68M

Return On Assets: -24.55

Return On Equity: -33.18

Profit Margin: N/A

Price History

Beta: 1.50

50-day Moving Avg: 42.89

200-day Moving Avg: 38.45

YTD Change: -0.75

5-day Change: -2.07

1-month Change: -18.34

3-month Change: -22.84

6-month Change: -11.91

1-year Change: 73.88

Revenue Per Share: 0.00

Revenue Per Employee: 49987.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Arena Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.arenapharm.com